| Product NDC: | 0574-0152 | 
| Proprietary Name: | Caffeine Citrate | 
| Non Proprietary Name: | CAFFEINE CITRATE | 
| Active Ingredient(s): | 20 mg/mL & nbsp; CAFFEINE CITRATE | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | SOLUTION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0574-0152 | 
| Labeler Name: | Paddock Laboratories, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA077304 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20060921 | 
| Package NDC: | 0574-0152-10 | 
| Package Description: | 10 VIAL in 1 CONTAINER (0574-0152-10) > 3 mL in 1 VIAL | 
| NDC Code | 0574-0152-10 | 
| Proprietary Name | Caffeine Citrate | 
| Package Description | 10 VIAL in 1 CONTAINER (0574-0152-10) > 3 mL in 1 VIAL | 
| Product NDC | 0574-0152 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | CAFFEINE CITRATE | 
| Dosage Form Name | SOLUTION | 
| Route Name | ORAL | 
| Start Marketing Date | 20060921 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Paddock Laboratories, Inc. | 
| Substance Name | CAFFEINE CITRATE | 
| Strength Number | 20 | 
| Strength Unit | mg/mL | 
| Pharmaceutical Classes | Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient] |